Global Enteric Disease Testing Market Growth: Industry Size, Analysis and Forecast
Report ID : 1316289 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Enteric Disease Testing Market is categorized based on Test Type (Nucleic Acid Amplification Tests (NAATs), Enzyme Immunoassays (EIAs), Rapid Test Kits, Culture Tests, Others) and Pathogen Type (Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections, Others) and End-User (Hospitals, Diagnostic Laboratories, Research Laboratories, Home Care Settings, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The market size of Enteric Disease Testing Market, valued at 3.5 billion USD in 2023, is projected to reach 6.2 billion USD by 2033, expanding at a CAGR of 6.1% between 2024 and 2033. The report comprises various segments and analyzes significant trends and factors influencing market growth.
The Enteric Disease Testing Market is a critical part from a segment in healthcare and diagnostics industry, which is influenced by the prevalence of gastrointestinal infections from bacterial, viral, and parasitic causes. These infections, along with their diagnostic needs, are increasing with the growth of the population and urban agglomerations. This increases the demand for precise and sensitive testing methods. Public health plays an important role to controlling measures through the early identification and the treatment of enteric diseases which helps in controlling morbidity and mortality, thus changing the market situation greatly.
In addition, new technology methods for testing such as molecular diagnostics and point of care have provided new ways of monitoring and diagnosis of enteric diseases. Innovations increase the speed & accuracy of result delivery, thus permitting timely response, treatment, and intervention frameworks. As more stakeholders understand the need for proper surveillance, monitoring of infectious diseases, and outbreaks, the market will greatly increase, therefore providing higher benefits for business and healthcare providers.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, Cepheid, Bio-Rad Laboratories, Meridian Bioscience, Hologic Inc., Becton, Dickinson and Company, Qiagen, Pall Corporation |
| SEGMENTS COVERED |
By Test Type - Nucleic Acid Amplification Tests (NAATs), Enzyme Immunoassays (EIAs), Rapid Test Kits, Culture Tests, Others
By Pathogen Type - Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections, Others
By End-User - Hospitals, Diagnostic Laboratories, Research Laboratories, Home Care Settings, Others
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Enteric Disease Testing Market Dynamics
The Enteric Disease Testing Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Enteric Disease Testing Market Segmentations
Market Breakup by Test Type
- Overview
- Nucleic Acid Amplification Tests (NAATs)
- Enzyme Immunoassays (EIAs)
- Rapid Test Kits
- Culture Tests
- Others
Market Breakup by Pathogen Type
- Overview
- Bacterial Infections
- Viral Infections
- Parasitic Infections
- Fungal Infections
- Others
Market Breakup by End-User
- Overview
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- Home Care Settings
- Others
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Enteric Disease Testing Market
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Roche Diagnostics
- Abbott Laboratories
- Thermo Fisher Scientific
- Danaher Corporation
- Cepheid
- Bio-Rad Laboratories
- Meridian Bioscience
- Hologic Inc.
- Becton
- Dickinson and Company
- Qiagen
- Pall Corporation
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved